metacognitive therapy for comorbid anxiety disorders: a case study.
Clicks: 215
ID: 244914
2016
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
30.0
/100
213 views
30 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
AbstractWe aimed to systematically evaluate a generic model of metacognitive therapy (MCT) with a highly comorbid anxiety disorder patient, that had been treated with diagnosis-specific cognitive-behavioral therapy (CBT) without significant effect. Traditionally, CBT has progressed within a disorder-specific approach, however it has been suggested that this could be less optimal with highly comorbid patients. To address comorbidity, transdiagnostic treatment models have been emerging. This case study used an AB-design with repeated assessments during each therapy session and a 1-year follow-up assessment to evaluate the effectiveness of MCT. Following 8 sessions of MCT, significant decrease in anxiety and depression symptoms, as well as loss of diagnostic status was observed. Outcomes were preserved at 12 months follow up. The generic model of MCT seems promising as an approach to highly comorbid mixed anxiety depression patients. Further testing using more powered methodologies are needed. Keywords: Metacognitive therapy, transdiagnostic, metacognition, anxiety, comorbidity.
| Reference Key |
johnson2016frontiersmetacognitive
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Sverre Urnes Johnson;Sverre Urnes Johnson;Asle Hoffart;Asle Hoffart |
| Journal | accounts of chemical research |
| Year | 2016 |
| DOI |
10.3389/fpsyg.2016.01515
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.